Skip to main content

D-Mart operator Avenue Supermarts reports 38% YoY fall in Q2 profit but grows 5-fold QoQ

 The company said it continued to focus on new stores and has opened six DMart stores during the quarter.

 

Avenue Supermarts, the operator of hypermarket retail chain D-Mart, has reported a 38.5 percent year-on-year decline in consolidated profit for the quarter ended September 2020 but sequentially, profit grew by five-fold amid easing of lockdown restrictions.

The company's revenue during the quarter also fell 11.4 percent to Rs 5,306.2 crore compared to the September quarter 2019 but there was 36.6 percent sequential growth.

"FMCG and staples demand remains robust. September 2020 sales of all stores exceeded September 2019 sales for FMCG and staples while general merchandise and garments did lesser sales in the same period," CEO & Managing Director Neville Noronha said.

However, "discretionary consumption has seen significant improvement over Q1FY21. We were at 22.7 percent revenue contribution from general merchandise and apparel business in Q2FY21 as compared to the usual 27.3 percent contribution for the year. Almost all of the shopping in Q1FY21 was need-based and essential in nature. In light of that, Q2FY21 sales contribution from general merchandise and apparel is encouraging," he added.

Other income also supported profitability, rising significantly to Rs 52.2 crore in the September quarter from Rs 8.1 crore YoY.

At the operating level, consolidated earnings before interest, tax, depreciation and amortisation (EBITDA) dropped 36 percent to Rs 329.5 crore and margin contracted 240 bps to 6.2 percent compared to thecorresponding quarter of last fiscal.



"Overall better-than-expected performance led by a quicker normalisation of overall business with a strong sequential recovery. We expected a decline of 15/47/49 percent for revenue/EBITDA/PAT respectively," Himanshu Nayyar, Lead Analyst–Institutional Equities, Yes Securities told Moneycontrol.

Gross margins were in line with expectations at 14 percent, given the inferior mix in the favour of FMCG and staples while EBITDA margins were impacted due to negative operating leverage, he said.

The company said it continued to focus on new stores and has opened six DMart stores in the quarter. "We have closed two of Mumbai stores for customers and converted them into fulfillment centers (FC) for our ecommerce business."

The stock gained only 5.2 percent during theSeptember quarter and 8 percent year-to-date.

After the recent underperformance, the stock is currently trading at 55x FY22E P/E and 35x EV/EBITDA, Nayyar said.

"While we have been negative on the stock given the risks to FY21 earnings and medium-term risk of multiple de-rating, the better-than-expected recovery trajectory and the correction in valuation multiples makes us turn more constructive on the stock. Increased focus and increasing traction in DMart Ready is another positive sign," he added.

Comments

Post a Comment

Popular posts from this blog

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...
Post a Comment
Read more

Check Chemcon Speciality Chemicals IPO allotment status in four simple steps

Equity shares will get credited into the accounts of eligible investors by September 30 and the listing of equity shares will be on October 1, 2020. Chemcon Speciality Chemicals, the manufacturer for pharmaceutical and oilfields industries, is expected to announce the basis of allotment early next week. As per the schedule provided by the company, the finalisation of the basis of the allotment will be done by September 28 and the initiation of refunds or unblocking of funds from ASBA account will take place on September 29. Equity shares will get credited to the accounts of eligible investors by September 30 and the listing will be on October The IPO comprised a fresh issue of Rs 165 crore and an offer for sale of Rs 153 crore by promoters. The company will utilise fresh issue proceeds for expansion of manufacturing facility, working capital requirements, and general corporate purposes. Chemcon manufactures specialised chemicals, such as Hexamethyldisilazane (HMDS) and Chloromethyl Iso...
Post a Comment
Read more

Taking Stock | Profit-booking pulls Nifty below 14,450; Sensex drops 549 points

  All the sectoral indices ended in the red with IT and PSU bank indices falling 2 percent each. The market remained under pressure on January 15 on the back of profit-booking across sectors amid weak global cues. At close, the Sensex was down 549.49 points or 1.11% at 49,034.67, and Nifty was down 161.90 points or 1.11% at 14,433.70. "The market witnessed profit-booking and following global trends. Nifty continues to resist 14,600 and has taken a dip towards 14,360. If the market closes below 14,380 levels, we might see a correction till the levels of 14,180-14,200. Momentum indicators like RSI, MACD are indicating a small correction in the markets," said Ashis Biswas, Head of Research at CapitalVia Global Research. All the sectoral indices ended in the red with IT and PSU bank falling 2 percent each. Broader markets performed in line with the main indices with BSE Midcap and Smallcap indices falling 1 percent each. Tech Mahindra, GAIL, HCL Tech, Wipro and ONGC...
Post a Comment
Read more